目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product & Application Snapshot
2.3. Anti-thrombotic & Anticoagulants Type Snapshot
2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis
4.1. Blood Preparation Market: Product Movement Analysis
4.2. Whole Blood
4.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
4.2.2. Red Cells
4.2.2.1. Red Cells Market, 2018 - 2030 (USD Million)
4.2.3. Granulocytes
4.2.3.1. Granulocytes Market, 2018 - 2030 (USD Million)
4.2.4. Plasma
4.2.4.1. Plasma Market, 2018 - 2030 (USD Million)
4.2.5. Platelets
4.2.5.1. Platelets Market, 2018 - 2030 (USD Million)
4.3. Blood Components
4.3.1. Whole Blood Components
4.3.1.1. Whole Blood Components Market, 2018 - 2030 (USD Million)
4.3.2. Packed Red Cells
4.3.2.1. Packed Red Cells Market, 2018 - 2030 (USD Million)
4.3.3. Leukocyte Reduced Red Blood Cells
4.3.3.1. Leukocyte Reduced Red Blood Cells Market, 2018 - 2030 (USD Million)
4.3.4. Frozen Plasma
4.3.4.1. Frozen Plasma Market, 2018 - 2030 (USD Million)
4.3.5. Platelet Concentrate
4.3.5.1. Whole Blood Components Market, 2018 - 2030 (USD Million)
4.3.6. Cryoprecipitate
4.3.6.1. Cryoprecipitate Market, 2018 - 2030 (USD Million)
4.4. Blood Derivatives
4.4.1. Blood Derivatives Market, 2018 - 2030 (USD Million)

Chapter 5. Anti-Thrombotic and Anticoagulants Type Business Analysis
5.1. Blood Preparation Market: Anti-Thrombotic and Anticoagulants Type Movement Analysis
5.2. Platelet Aggregation Inhibitors
5.2.1. Platelets Aggregation Inhibitors Market, 2018 - 2030 (USD Million)
5.2.2. Glycoprotein Inhibitors
5.2.2.1. Glycoprotein Inhibitors Market, 2018 - 2030 (USD Million)
5.2.3. COX Inhibitors
5.2.3.1. COX Inhibitors Market, 2018 - 2030 (USD Million)
5.2.4. ADP Antagonist
5.2.4.1. ADP Antagonist Market, 2018 - 2030 (USD Million)
5.2.5. Others
5.2.5.1. Others Market, 2018 - 2030 (USD Million)
5.3. Fibrinolytics
5.3.1. Fibrinolytics Market, 2018 - 2030 (USD Million)
5.3.2. Tissue Plasminogen Activator
5.3.2.1. Others Market, 2018 - 2030 (USD Million)
5.3.3. Streptokinase
5.3.3.1. Streptokinase Market, 2018 - 2030 (USD Million)
5.3.4. Urokinase
5.3.4.1. Urokinase Market, 2018 - 2030 (USD Million)
5.4. Anticoagulants
5.4.1. Anticoagulants Market, 2018 - 2030 (USD Million)
5.4.2. Heparins
5.4.2.1. Heparins Market, 2018 - 2030 (USD Million)
5.4.2.2. Unfractionated heparin
5.4.2.2.1. Unfractionated heparin Market, 2018 - 2030 (USD Million)
5.4.2.3. Low Molecular Weight heparin
5.4.2.3.1. Low Molecular Weight Heparin Market, 2018 - 2030 (USD Million)
5.4.2.4. Ultra-Low Molecular Weight Heparin
5.4.2.4.1. Ultra-Low Molecular Weight Heparin Market, 2018 - 2030 (USD Million)
5.4.3. Vitamin K Antagonist
5.4.3.1. Vitamin K Antagonist Market, 2018 - 2030 (USD Million)
5.4.4. Direct Thrombin Inhibitors
5.4.4.1. Direct Thrombin Inhibitors Market, 2018 - 2030 (USD Million)
5.4.5. Direct factor Xa inhibitors
5.4.5.1. Direct factor Xa Inhibitors Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis
6.1. Thrombocytosis
6.1.1. Thrombocytosis Market, 2018 - 2030 (USD Million)
6.2. Pulmonary Embolism
6.2.1. Pulmonary Embolism Market, 2018 - 2030 (USD Million)
6.3. Renal Impairment
6.3.1. Renal Impairment Market, 2018 - 2030 (USD Million)
6.4. Angina Blood Vessel Complication
6.4.1. Angina Blood Vessel Complication Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis
7.1. Blood Preparation Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Blood Preparation Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Blood Preparation Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Blood Preparation Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Blood Preparation Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Blood Preparation Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Blood Preparation Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Blood Preparation Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Blood Preparation Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Blood Preparation Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Blood Preparation Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Blood Preparation Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Blood Preparation Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Blood Preparation Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Blood Preparation Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Blood Preparation Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Blood Preparation Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Strategic Framework
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Pfizer, Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Bristol-Myers Squibb Company
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Leo Pharma A/S
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Sanofi
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Xiamen Hisunny Chemical Co., LTD
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AstraZeneca plc
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Baxter International Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Blood Preparation Market, by Product, 2018 - 2030 (USD Million)
Table 4. Global Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 5. Global Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 6. Global Blood Preparation Market, by Region, 2018 - 2030 (USD Million)
Table 7. North America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 8. North America Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 9. North America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 10. North America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 11. U.S. Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 12. U.S. Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 13. U.S. Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 14. Canada Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 15. Canada Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 16. Canada Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 17. Europe Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 18. Europe Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 19. Europe Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 20. Europe Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 21. Germany Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 22. Germany Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 23. Germany Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 24. UK Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 25. UK Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 26. UK Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 27. France Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 28. France Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 29. France Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 30. Italy Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 31. Italy Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 32. Italy Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 33. Spain Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 34. Spain Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 35. Spain Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 36. Sweden Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 37. Sweden Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 38. Sweden Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 39. Denmark Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 40. Denmark Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 41. Denmark Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 42. Norway Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 43. Norway Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 44. Norway Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 45. Asia Pacific Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 49. China Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 50. China Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 51. China Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 52. Japan Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 53. Japan Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 54. Japan Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 55. India Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 56. India Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 57. India Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 58. South Korea Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 59. South Korea Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 60. South Korea Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 61. Australia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 62. Australia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 63. Australia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 64. Thailand Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 65. Thailand Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 66. Thailand Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 67. Latin America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 68. Latin America Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 69. Latin America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 70. Latin America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 71. Brazil Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 72. Brazil Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 73. Brazil Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 74. Mexico Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 75. Mexico Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 76. Mexico Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 77. Argentina Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 78. Argentina Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 79. Argentina Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 84. South Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 85. South Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 86. South Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 90. UAE Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 91. UAE Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 92. UAE Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 93. Kuwait Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 94. Kuwait Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 95. Kuwait Blood Preparation Market, by Application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Blood Preparation, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Blood Preparation Market: Product Movement Analysis
Fig. 17 Global Blood Preparation Market, for Whole Blood,2018 - 2030 (USD Million)
Fig. 18 Global Blood Preparation Market, for Red Cells,2018 - 2030 (USD Million)
Fig. 19 Global Blood Preparation Market, for Granulocytes,2018 - 2030 (USD Million)
Fig. 20 Global Blood Preparation Market, for Plasma ,2018 - 2030 (USD Million)
Fig. 21 Global Blood Preparation Market, for Platelets,2018 - 2030 (USD Million)
Fig. 22 Global Blood Preparation Market, for Blood Components,2018 - 2030 (USD Million)
Fig. 23 Global Blood Preparation Market, for Whole Blood Components,2018 - 2030 (USD Million)
Fig. 24 Global Blood Preparation Market, for Packed Red Cells,2018 - 2030 (USD Million)
Fig. 25 Global Blood Preparation Market, for Leukocyte Reduced Red Blood Cells,2018 - 2030 (USD Million)
Fig. 26 Global Blood Preparation Market, for Frozen Plasma,2018 - 2030 (USD Million)
Fig. 27 Global Blood Preparation Market, for Platelet Concentrate,2018 - 2030 (USD Million)
Fig. 28 Global Blood Preparation Market, for Cryoprecipitate,2018 - 2030 (USD Million)
Fig. 29 Global Blood Preparation Market, for Blood Derivatives,2018 - 2030 (USD Million)
Fig. 30 Global Blood Preparation Market: Antithrombotic & Anticoagulants Type Movement Analysis
Fig. 31 Global Blood Preparation Market, for Platelet Aggregation Inhibitors,2018 - 2030 (USD Million)
Fig. 32 Global Blood Preparation Market, for Glycoprotein Inhibitors,2018 - 2030 (USD Million)
Fig. 33 Global Blood Preparation Market, for COX Inhibitors,2018 - 2030 (USD Million)
Fig. 34 Global Blood Preparation Market, for ADP Antagonists,2018 - 2030 (USD Million)
Fig. 35 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
Fig. 36 Global Blood Preparation Market, for Fibrinolytics,2018 - 2030 (USD Million)
Fig. 37 Global Blood Preparation Market, for Tissue Plasminogen Activator (tPA),2018 - 2030 (USD Million)
Fig. 38 Global Blood Preparation Market, for Streptokinase,2018 - 2030 (USD Million)
Fig. 39 Global Blood Preparation Market, for Urokinase,2018 - 2030 (USD Million)
Fig. 40 Global Blood Preparation Market, for Anticoagulants,2018 - 2030 (USD Million)
Fig. 41 Global Blood Preparation Market, for Heparins,2018 - 2030 (USD Million)
Fig. 42 Global Blood Preparation Market, for Unfractionated Heparin,2018 - 2030 (USD Million)
Fig. 43 Global Blood Preparation Market, for Low Molecular Weight Heparin (LMWH),2018 - 2030 (USD Million)
Fig. 44 Global Blood Preparation Market, for Ultra-low Molecular Weight Heparin,2018 - 2030 (USD Million)
Fig. 45 Global Blood Preparation Market, for Vitamin K Antagonists,2018 - 2030 (USD Million)
Fig. 46 Global Blood Preparation Market, for Direct Thrombin Inhibitors,2018 - 2030 (USD Million)
Fig. 47 Global Blood Preparation Market, for Direct Factor Xa Inhibitors,2018 - 2030 (USD Million)
Fig. 48 Global Blood Preparation Market, : Application Movement Analysis
Fig. 49 Global Blood Preparation Market, for Thrombocytosis,2018 - 2030 (USD Million)
Fig. 50 Global Blood Preparation Market, for Pulmonary Embolism,2018 - 2030 (USD Million)
Fig. 51 Global Blood Preparation Market, for Renal Impairment,2018 - 2030 (USD Million)
Fig. 52 Global Blood Preparation Market, for Angina Blood Vessel Complications,2018 - 2030 (USD Million)
Fig. 53 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
Fig. 54 Regional Marketplace: Key Takeaways
Fig. 55 Regional Outlook, 2022 & 2030
Fig. 56 Global Blood Preparation Market, : Region Movement Analysis
Fig. 57 North America Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 58 U.S. Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 59 Canada Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 60 Europe Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 61 Germany Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 62 UK Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 63 France Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 64 Italy Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 65 Spain Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 66 Sweden Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 67 Denmark Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 68 Norway Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 70 Japan Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 71 China Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 72 India Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 73 Australia Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 74 South Korea Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 75 Thailand Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 76 Latin America Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 77 Brazil Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 78 Mexico Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 79 Argentina Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 80 Middle East and Africa Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 81 South Africa Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 83 UAE Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 84 Kuwait Blood Preparation Market, 2018 - 2030 (USD Million)